Johnson & Johnson (JNJ) Goodwill & Intangibles (2009 - 2026)
Johnson & Johnson's (JNJ) quarterly Goodwill & Intangibles came in at $96.7 billion in Q2 2026, down 1.27% year-over-year from $98.0 billion in Q2 2025, and down 0.93% quarter-over-quarter from $97.6 billion in Q1 2026.
Analysis
Johnson & Johnson (JNJ) Goodwill & Intangibles (2009 - 2026) Analysis & Trends
Johnson & Johnson has disclosed Goodwill & Intangibles across 18 years of filings, most recently posting $96.7 billion for Q2 2026.
- In Q2 2026, Goodwill & Intangibles fell 1.27% year-over-year to $96.7 billion; the TTM figure through Jun 2026 stood at $96.7 billion (down 1.27% YoY), while the FY2025 annual figure was $99.2 billion, up 21.21% from the prior year.
- Goodwill & Intangibles came in at $96.7 billion for Q2 2026 at Johnson & Johnson, down from $97.6 billion in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $99.2 billion in Q4 2025 to a low of $70.7 billion in Q4 2023.
- Average Goodwill & Intangibles over 5 years is $83.8 billion, with a median of $81.8 billion recorded in 2024.
- Year-over-year, Goodwill & Intangibles fell 23.78% in 2024 and increased 21.21% in 2025.
- Over 5 years, Goodwill & Intangibles stood at $73.7 billion in 2022, then retreated by 4.05% to $70.7 billion in 2023, then advanced by 15.67% to $81.8 billion in 2024, then climbed by 21.21% to $99.2 billion in 2025, then fell by 2.49% to $96.7 billion in 2026.
- Per Business Quant data, the three most recent Goodwill & Intangibles figures were $96.7 billion in Q2 2026, $97.6 billion in Q1 2026, and $99.2 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 96.71 Bn |
| Mar 29, 2026 | 97.62 Bn |
| Dec 28, 2025 | 99.18 Bn |
| Sep 28, 2025 | 96.79 Bn |
| Jun 29, 2025 | 97.95 Bn |
| Mar 30, 2025 | 81.22 Bn |
| Dec 29, 2024 | 81.82 Bn |
| Sep 29, 2024 | 84.29 Bn |
| Jun 30, 2024 | 83.98 Bn |
| Mar 31, 2024 | 70.90 Bn |
| Dec 31, 2023 | 70.73 Bn |
| Oct 1, 2023 | 71.15 Bn |
| Jul 2, 2023 | 91.69 Bn |
| Apr 2, 2023 | 93.02 Bn |
| Jan 1, 2023 | 74.54 Bn |
| Oct 2, 2022 | 73.72 Bn |
| Jul 3, 2022 | 76.57 Bn |
| Apr 3, 2022 | 79.36 Bn |
| Jan 2, 2022 | 71.83 Bn |
| Oct 3, 2021 | 83.35 Bn |